Latest News and Press Releases

Beamion LUNG-1, Phase Ib met its primary endpoint, demonstrating a meaningful objective response rate (ORR) of 66.7%, as assessed by blinded independent central review (BICR)1Preliminary activity in...

The company sets new standards in precision and value, advancing its product line with innovative optics and expanding its international presence.

IRVING, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- As Texas continues to grow as a biotech and healthcare innovative hub, BioNTX is honored to announce the 2024 Rising Stars, a select group of...

Dallas, TX, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a global pioneer in wearable neurostimulation solutions, proudly announces the launch of Sparrow Link, a revolutionary research...

PHILADELPHIA, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The Alliance for Decision Education (the Alliance), a national nonprofit organization leading the movement to have decision-making be part of every...

Digital Science today announces the launch of Papers Pro, an AI-enhanced premium version of its acclaimed reference manager, Papers.

Fractyl Health to Participate in Upcoming September Investor Conferences

Foundation for Sarcoidosis Research appoints fourteen new members to serve the organization’s Scientific Advisory Board.

Data from the phase Ib Beamion LUNG-1 trial selected for late-breaking oral presentation in the Presidential Symposium at WCLC on Monday, September 9. The U.S. FDA and China's CDE have granted...

Golden, CO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Researchers at the U.S. Department of Energy’s National Renewable Energy Laboratory (NREL) see a realistic path forward to the manufacture of...